Risks of safety Qingkailing oral preparation

doi:10.19803/j.1672-8629.20220676

Abstract

Abstract: Objective To analyze the risk of Qingkailing oral preparation in order to provide reference for rational clinical use. Methods Cases of adverse reactions related to Qingkailing oral preparation that were retrieved from National ADR Monitoring System and literature , and the relevant control measures issued by regulatory agencies were analyzed. Results From 2015 to 2021, the National ADR Monitoring System has received 7 185 ADR/ADE reports involving Qingkailing oral preparations, which involved gastrointestinal, skin, nervous and other systems and organs. The systems and organs literature reports involved in ADR/ADE of Qingkailing oral preparations were basically consistent with the reports in National ADR Monitoring System. Conclusion Adverse drug reaction associated with oral preparations of Qingkailing involve multiple systems-organs, and clinical attention should be paid to the adverse reactions associated with oral preparations of Qingkailing to promote the safe and rational use of drugs.

Key words: Qingkailing, oral preparation, safety, adverse reaction

CLC Number:

R994.11

YU Hongli, YU Dongmei, XIAO Aili, ZHU Lan, SONG Haibo. Risks of safety Qingkailing oral preparation[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1046-1048.

References

[1] DONG GB.To compare the clinical efficacy of Qingkailing dispersible tablet and Lianhua Qingwen capsule in the treatment of viral cold and fever[J]. World Latest Medicine Information(世界最新医学信息文摘), 2015, 15(55): 70-71.
[2] LIN M, XIONG LJ, CHEN XE, et al.Efficacy analysis of domestic oseltamivir combined with Qingkailing granule in the treatment of influenza A in children[J]. Fujian Medical Journal(福建医药杂志), 2019, 41(1): 74-76.
[3] ZHEN JD.Comparison of antiviral oral liquid and Qingkailing capsule in the treatment of epidemic mumps in children[J]. Contemporary Medical Symposium(当代医药论丛), 2019, 17(8): 137-138.
[4] WU XJ, SU BZ, WU LZ, et al.Curative effect of Qingkailing dropping pills on chronic pharyngitis and its effect on serum EGF IL-1 β impact of VCAM-1[J]. Hebei Medicine(河北医学), 2018, 24(12): 1960-1965.
[5] LI Z.Observation on the curative effect of Qingkailing dispersible tablet and Lianhua Qingwen capsule in the treatment of 150 cases of viral cold and fever[J]. Seek Medical and Ask the Medicine(求医问药), 2012, 10(9): 659-660.
[6] SUN YY, LI MX, QIN N.Comparative study on clinical efficacy of Qingkailing and Lianhua Qingwen capsules in relieving symptoms of upper respiratory tract infection[J]. Contemporary Medicine(当代医学), 2020, 26(24): 95-97.
[7] HU JF.Qingkailing combined with cefoperazone sodium/observation on the efficacy of sulbactam sodium in the treatment of senile emphysema complicated with infection[J]. Chinese Journal of Clinical Rational Drug Use(临床合理用药), 2018, 11(10A): 58-59.
[8] PENG Z.Clinical efficacy of Qingkailing combined with drugs in the treatment of elderly patients with emphysema complicated with infection[J]. Contemporary Medicine(当代医学), 2018, 24(3): 121-123.
[9] MO GC.Clinical effect of Qingkailing in the treatment of acute upper respiratory tract infection with high fever[J]. Journal of SNAKE(蛇志), 2017, 29(4): 451-452.
[10] NI WD, CHEN X.To explore the efficacy of ceftizoxime sodium combined with Qingkailing in the treatment of senile emphysema complicated with infection[J]. Global Traditional Chinese Medicine(环球中医药), 2014, 7(S2): 40-41.
[11] MEN LT.Efficacy analysis of cefuroxime sodium combined with Qingkailing in the treatment of senile emphysema[J]. Health Protection and Promotion(现代养生), 2018, 323(10): 102-103.
[12] ZHONG J.Effect and pharmacological action of ceftriaxone sodium combined with Qingkailing on acute infective endocarditis[J].Journal of North Pharmacy(北方药学), 2019, 16(9): 132-133.
[13] ZHANG DM, HOU XG.124 cases of infantile upper fever treated with Kailing granule[J]. Traditional Chinese Medicinal Research(中医研究), 2000, 13(4): 30-31.
[14] XU XY, ZHANG J, PAN Y.A case of severe erythema multiforme drug eruption caused by Qingkailing dispersible tablets[J]. Chinese Journal of Pharmacoepidemiology(药物流行病学杂志), 2013, 22(8): 460-461.
[15] JIN H.Effect of Qingkailing dispersible tablet and Lianhua Qingwen capsule on viral cold and fever[J]. Journal of North Pharmacy(北方药学), 2016, 13(1): 26-27.
[16] National Medical Products Administration. Announcement of the NMPA on Revising the instructions of Qingkailing oral preparations [EB/OL]. (2021-05-12) [2022-08-04]. https://www.nmpa.gov.cn/xxgk/ggtg/ypshmshxdgg/20210512104440187.html.